# Study of Nonculture Epidermal Suspension in the Treatment of Stable Vitiligo

## TL;DR

Nonculture epidermal suspension is a safe and effective treatment for stable vitiligo, with long-term repigmentation benefits observed in patients.

## Contribution

This study provides clinical evidence of the long-term efficacy and safety of nonculture epidermal suspension in treating stable vitiligo.

## Key findings

- Mean repigmentation of 68% was achieved with 43.1% of patients showing excellent results.
- 78% of patients maintained stable repigmentation over two years of follow-up.
- Only 13.7% of patients experienced minor adverse events with no serious complications.

## Abstract

Vitiligo is a chronic autoimmune disorder characterized by skin depigmentation. Nonculture epidermal suspension has emerged as a promising treatment for stable vitiligo.

This article evaluates the efficacy and safety of nonculture epidermal suspension in patients with stable vitiligo.

Fifty-one patients with stable vitiligo underwent nonculture epidermal suspension treatment between 2016 and 2022. Repigmentation was assessed at 1 month, 3 months, 6 months, and 1 year. Factors affecting outcomes were analyzed.

The mean repigmentation was 68% (95% confidence interval: 62.7–73.9%) with 43.1% of patients achieving excellent repigmentation. Long-term follow-up (> 2 years) in 32 patients showed 78% maintained stable repigmentation. Minor adverse events occurred in 13.7% of patients with no serious complications reported.

Nonculture epidermal suspension is an effective, simple, and safe procedure for stable vitiligo with sustained long-term results.